Correlation Between Pmv Pharmaceuticals and Relmada Therapeutics

Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and Relmada Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and Relmada Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pmv Pharmaceuticals and Relmada Therapeutics, you can compare the effects of market volatilities on Pmv Pharmaceuticals and Relmada Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of Relmada Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and Relmada Therapeutics.

Diversification Opportunities for Pmv Pharmaceuticals and Relmada Therapeutics

0.31

Correlation Coefficient

Pmv Pharmaceuticals  Relmada Therapeutics

Weak diversification

The 3 months correlation between Pmv and Relmada is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and Relmada Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Relmada Therapeutics and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with Relmada Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Relmada Therapeutics has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and Relmada Therapeutics go up and down completely randomly.

Pair Corralation between Pmv Pharmaceuticals and Relmada Therapeutics

Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to generate 0.39 times more return on investment than Relmada Therapeutics. However, Pmv Pharmaceuticals is 2.53 times less risky than Relmada Therapeutics. It trades about -0.23 of its potential returns per unit of risk. Relmada Therapeutics is currently generating about -0.21 per unit of risk. If you would invest  144.00  in Pmv Pharmaceuticals on December 4, 2024 and sell it today you would lose (15.00) from holding Pmv Pharmaceuticals or give up 10.42% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Pmv Pharmaceuticals  vs.  Relmada Therapeutics

Pmv Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pmv Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Relmada Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Relmada Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's primary indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Pmv Pharmaceuticals and Relmada Therapeutics

The main advantage of trading using opposite Pmv Pharmaceuticals and Relmada Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, Relmada Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Relmada Therapeutics will offset losses from the drop in Relmada Therapeutics' long position.

The idea behind Pmv Pharmaceuticals and Relmada Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.